Further Data Confirms POLB 001’s Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS) Market opportunity estimated to be greater than US$1 billion
Poolbeg Pharma PLC (AIM:POLB) Former Amryt Pharma Leadership Team join Poolbeg
Key Senior Members of Former Amryt Pharma Leadership Team join Poolbeg Pharma Poolbeg team boosted by highly experienced executives with track record of success
Novacyt S.A. (NCYT.L) Proposed accounting treatment of DHSC dispute
Proposed accounting treatment of ongoing DHSC dispute in 2021 interim results
Novacyt S.A. (NCYT.L) Notice of AGM
Paris, France and Camberley, UK – 20 August 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces that its Annual General Meeting
Novacyt S.A. (NCYT.L) Notice of investor meeting
Paris, France and Camberley, UK – 5 August 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), a leading international specialist in clinical diagnostics, announces that it will hold
Novacyt S.A. (NCYT.L) David Allmond to be CEO, Graham Mullis to retire
Paris, France and Camberley, UK – 29 July 2021 – Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), a leading international specialist in clinical diagnostics, announces the appointment of David